A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
Clinical trial NCT02322086 · COMPLETED
Trial details
- NCT number
- NCT02322086
- Sponsor
- Provectus Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.